Table 3

The detailed patient data.

Case number
Gender
Diagnosis
Result
Reported/Novel
HRM result
FVIII:C
Severity

69-1
M
Affected case
Exon 1 deletion
R

<1%
severe
61-1
M
Affected case
Exon 2, c.185, C>G, TCA>TGA, Ser>X
N

<1%
severe
109
M
Affected case
Exon 3, c.278, C>T, CCT>CTT, Pro>Leu
N
V
<1%
severe
82
M
Affected case
Exon 3, c.278, C>T, CCT>CTT, Pro>Leu
N

<1%
severe
144
M
Affected case
Exon 3, c.336_339, dup CCAT
N
indistinguishable
1.6%
moderate
71-1
F
Carrier
Intron 3, c.289-9 C>T
N
V


42-3
M
Affected case
Exon 4, c.403 G>A, GAT>AAT, Asp>Asn
N

<1%
severe
59-1
M
Affected case
Exon 4, c.532, C>G, CTT>GTT, Leu>Val
N

<1%
severe
118-1
M
Affected case
Exon 4~Exon 10 deletion
R

1.1%
moderate
122
M
Affected case
Exon 7, c.829, A>G, ATT>GTT, Asp>Gly
N
V
12%
muld
114
M
Affected case
Exon 7, c.854_855, ins G
N
V
2.4%
moderate
79-1
M
Affected case
Exon 7, c.977 T>C, CTA>CCA, Leu>Pro
R

<1%
severe
94-1
M
Affected case
Exon 7, c.977 T>C, CTA>CCA, Leu>Pro
R

<1%
severe
16-3
M
Affected case
Exon 8, c.1247, C>T, CCC>CTC, Pro>Leu
N

4.2%
moderate
101
F
Carrier
Exon 9, c.1310 G>C, CGG>CCG, Arg>Pro
R
V


72-1
M
Affected case
Exon 9, c.1315 G>A, GGT>AGT, Gly>Ser
R

3.0%
moderate
162
M
Affected
Exon 9, c.1336, C>T, CGA>TGA, Arg>X
R

4.8%
moderate
110
M
Affected case
Exon 9, c.1400, T>G, ATC>AGC, Ile>Ser
N
V
0.6%
severe
65
M
Affected case
Exon 11, c.1636, C>T, CGG>TGG, Arg>Trp
R

2.3%
moderate
92
M
Affected case
Exon 11, c.1648, C>T, CGC>TGC, Arg>Cys
R

12.0%
mild
136
M
Affected case
Exon 11, c.1678, A>G, AGA>GAA, Arg>Gly
N
V
11.0%
moderate
98
M
Affected case
Exon 12, c.1783_1790 del 8 mer
N
V
<1%
severe
119
M
Affected case
Exon 12, c.1804, C>T, CGA>TGA.Arg>X
R
V
1.5%
moderate
150-1
M
Affected case
Exon 12, c.1834, C>T, CGC>TGC, Arg>Cys
R

6.0%
mild
10-1
M
Affected case
Exon 14, c.2314 C>T, CAA>TAA, Gln>X
R

<1%
severe
104-1
M
Affected case
Exon 14, c.2605_2606, ins C
N
V
<1%
severe
113-1
M
Affected case
Exon 14, c.2609_2610, del CT
R
V
<1%
severe
85-1
M
Affected case
Exon 14, c.2939_2940, ins G
N
V
<1%
severe
124
M
Affected case
Exon 14, c.3294_3295, ins A
N
V
0.2%
severe
111
M
Affected case
Exon 14, c.3629, del A
R
V
<1%
severe
17-1
F
Carrier
Exon 14, c.3629, del A
R



3-1
M
Affected case
Exon 14, c.3629, del A
R

<1%
severe
132
M
Affected case
Exon 14, c.4076 G>A, TGG>TAG, Trp>X
R

0.3%
severe
87-1
M
Affected case
Exon 14, c.4197 del C
N

3.0%
moderate
63-1
M
Affected case
Exon 14, c.4372, del A
N

3.6%
moderate
2-1
M
Affected case
Exon 14, c.4619, del T
N

<1%
severe
11-1
F
Affected case
Exon14, c.4814, C>A, TCA>TAA, Ser>X
R

2.0%
moderate
57-2
M
Affected case
Exon 14, c.4856, del C
R

<1%
severe
67-3
M
Affected case
Exon 14, c.4942 C>T, CAA>TAA, Gln>X


2.6%
moderate
115-1
M
Affected case
Exon 14, c.5069_5073, del 5 mer
R
V
<1%
severe
74
M
Affected case
Exon14, c.5143, C>T, CGA>TGA, Arg>X
N

<1%
severe
39-3
M
Affected case
Exon 15, c5343 T>A, TATA>TAA, Tyr>X
N

<1%
severe
48-5
M
Affected case
Exon 15, c.5353, G>A, GAA>AAA, Glu>Lys
N
V
3.7%
moderate
159-2
M
Affected case
Exon 16, c.5399, G>A, CGT>CAT, Arg>His
R

4.5%
moderate
97
M
Affected case
Exon 16, c.5465_5466, insA
N

4.9%
moderate
55-1
M
Affected case
Exon 16, c.5526, G>A, ATG>ATA, Met>Ile
R

2.1%
moderate
5-2
M
Affected case
Exon 16, c.5536, T>A, AAA>TAA, Lys>X
R

1.6%
moderate
123
M
Affected case
Exon 16, c.5576, A>G, GAT>GGT, Asp>Gly
N
indistinguishable
1.3%
moderate
161-1
F
Carrier
Exon 17, c.5711, A>G, GAG>GGG, Glu>Gly
N
V


56-1
M
Affected case
Exon 17, c.5848, C>T, CGA>CAA, Gln>X
N

<1%
severe
1-1
M
Affected case
Exon 18, c.5879, G>A, CGA>CAA, Arg>Gln
R

7.4%
mild
133
M
Affected case
Exon 18, c.5879, G>A, CGA>CAA, Arg>Gln
R

5.5%
mild
107-1
M
Affected case
Exon 18, c.5953, C>T, CGA>TGA, Arg>X
R
V
0.8%
severe
138-2
M
Affected case
Exon 18, c.5953, C>T, CGA>TGA, Arg>X
R

<1%
severe
73
M
Affected case
Exon 22, c.6403, C>T, CGA>TGA, Arg>X
N

<1%
severe
14-2
M
Affected case
Exon 23, c.6506, G>A, CGT>CAT, Arg>His
R

25%
mild
20-1
M
Affected case
Exon 23, c.6506, G>A, CGT>CAT, Arg>His
R

2.9%
moderate
139-1
M
Affected case
Exon 23, c.6506, G>A, CGT>CAT, Arg>His
R
V
3.0%
moderate
125
M
Affected case
Exon 23, c.6532, C>T, CGC>TGC, Arg>Cys
R

6.5%
mild
170-1
M
Affected case
Exon 23, c.6532 C>T, CGC>TGC, Arg>Cys
R
V
8.9%
mild
174-1
M
Affected case
Exon 23, c.6532 C>T, CGC>TGC, Arg>Cys
R
V
8.4%
mild
95-1
M
Affected case
Exon 23, c.6545, G>A, CGC>CAC, Arg>His
R
V
2.5%
moderate
38-3
M
Affected case
Exon 24, c. 6575 G>T, AGT>ATT, Ser>Ile
R

7.2%
mild
102-1
M
Affected case
Exon 24, c.6671, C>T, CCT>CTT, Pro>Leu
R
V
2.7%
moderate
12-1
F
Affected case
Exon 24, c.6683 G>A, CGA> CAA, Arg>Gln
R

<1%
severe
41-3
M
Affected case
Exon 25, c.6724, G>A, GTG>ATG, Val>Met; Exon 8, c.1172, G>A, CGC>CAC, Arg>His
R;R
indistibuishable; V
<1%
severe
84-1
M
Affected case
Exon 25, c.6794_6795 del AG
R
indistinguishable
<1%
severe
93-1
M
Affected case
Intron 1 inversion
R

12.0%
mild
21-1
M
Affected case
Intron 22 inversion/Exon14 c.4531, G>A, GTT>ATT, Val>Ile
R;N
V
<1%
severe
100
M
Affected case
Intron 22 inversion
R

<1%
severe
103-1
F
Carrier
Intron 22 inversion
R



105
M
Affected case
Intron 22 inversion
R

<1%
severe
106-1
M
Affected case
Intron 22 inversion
R

<1%
severe
112-1
M
Affected case
Intron 22 inversion
R

1.2%
moderate
116-1
M
Affected case
Intron 22 inversion
R

<1%
severe
117
M
Affected case
Intron 22 inversion
R

3.0%
moderate
120-1
M
Affected case
Intron 22 inversion
R

2.0%
moderate
121
M
Affected case
Intron 22 inversion
R

0.6%
severe
126-1
M
Affected case
Intron 22 inversion
R

<1%
severe
131-1
M
Affected case
Intron 22 inversion
R

<1%
severe
13-4
M
Affected case
Intron 22 inversion
R

<1%
severe
140
M
Affected case
Intron 22 inversion
R

1.1%
moderate
143-1
M
Affected case
Intron 22 inversion
R

3.0%
moderate
147
M
Affected case
Intron 22 inversion
R

0.5%
severe
149-2
M
Affected case
Intron 22 inversion
R

<1%
severe
151
M
Affected case
Intron 22 inversion
R

1.4%
moderate
15-1
M
Affected case
Intron 22 inversion
R

<1%
severe
152
M
Affected case
Intron 22 inversion
R

2.1%
moderate
153
M
Affected case
Intron 22 inversion
R

1.8%
moderate
154
M
Affected case
Intron 22 inversion
R

0.5%
severe
155
M
Affected case
Intron 22 inversion
R

1.7%
moderate
156
M
Affected case
Intron 22 inversion
R

1.8%
moderate
164
M
Affected case
Intron 22 inversion
R

<1%
severe
167
M
Affected case
Intron 22 inversion
R

<1%
severe
181
M
Affected case
Intron 22 inversion
R

3.0%
moderate
31-7
F
Carrier
Intron 22 inversion
R



33-3
M
Affected case
Intron 22 inversion
R

<1%
severe
34-1
M
Affected case
Intron 22 inversion
R

<1%
severe
35-1
M
Affected case
Intron 22 inversion
R

3.0%
moderate
40-2
M
Affected case
Intron 22 inversion
R

<1%
severe
47-1
M
Affected case
Intron 22 inversion
R

3.2%
moderate
58-3
M
Affected case
Intron 22 inversion
R

<1%
severe
60-1
M
Affected case
Intron 22 inversion
R

1.6%
moderate
6-1
M
Affected case
Intron 22 inversion
R

<1%
severe
51-1
M
Affected case
Intron 22 inversion
R

2.7%
moderate
62-1
M
Affected case
Intron 22 inversion
R

<1%
severe
64-2
M
Affected case
Intron 22 inversion
R

<1%
severe
68-1
M
Affected case
Intron 22 inversion
R

<1%
severe
70-1
M
Affected case
Intron 22 inversion
R

<1%
severe
75-2
M
Affected case
Intron 22 inversion
R

<1%
severe
76-1
M
Affected case
Intron 22 inversion
R

<1%
severe
77-1
M
Affected case
Intron 22 inversion
R

<1%
severe
81
M
Affected case
Intron 22 inversion
R

<1%
severe
86-2
M
Affected case
Intron 22 inversion
R

<1%
severe
88-1
M
Affected case
Intron 22 inversion
R

<1%
severe
89-1
M
Affected case
Intron 22 inversion
R

<1%
severe
90
M
Affected case
Intron 22 inversion
R

0.8%
severe
91
M
Affected case
Intron 22 inversion
R

1.1%
moderate
9-1
M
Affected case
Intron 22 inversion
R

<1%
severe
96-2
M
Affected case
Intron 22 inversion
R

0.5%
severe
99
M
Affected case
Intron 22 inversion
R

<1%
severe
148
M
Affected case
Intron 22 inversion
R

<1%
severe

Lin et al. BMC Medical Genetics 2008 9:53   doi:10.1186/1471-2350-9-53